tiprankstipranks
Fresenius SE price target raised to EUR 40 from EUR 38 at Barclays
PremiumThe FlyFresenius SE price target raised to EUR 40 from EUR 38 at Barclays
3M ago
Fresenius SE price target raised to EUR 41 from EUR 40 at Morgan Stanley
Premium
The Fly
Fresenius SE price target raised to EUR 41 from EUR 40 at Morgan Stanley
3M ago
Fresenius SE price target raised to EUR 44 from EUR 42 at Deutsche Bank
Premium
The Fly
Fresenius SE price target raised to EUR 44 from EUR 42 at Deutsche Bank
4M ago
Fresenius SE price target raised to EUR 40 from EUR 39 at Morgan Stanley
PremiumThe FlyFresenius SE price target raised to EUR 40 from EUR 39 at Morgan Stanley
7M ago
Fresenius SE price target raised to EUR 38 from EUR 36.50 at Barclays
Premium
The Fly
Fresenius SE price target raised to EUR 38 from EUR 36.50 at Barclays
7M ago
Fresenius SE upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Fresenius SE upgraded to Overweight from Equal Weight at Morgan Stanley
7M ago
Fresenius SE launches biosimilar of Roche’s Actemra
PremiumThe FlyFresenius SE launches biosimilar of Roche’s Actemra
11M ago
Fresenius SE price target raised to EUR 41 from EUR 39 at Deutsche Bank
Premium
The Fly
Fresenius SE price target raised to EUR 41 from EUR 39 at Deutsche Bank
12M ago
Fresenius SE price target lowered to EUR 43 from EUR 44.50 at Berenberg
Premium
The Fly
Fresenius SE price target lowered to EUR 43 from EUR 44.50 at Berenberg
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100